PHILADELPHIA– October 19, 2015 –– ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions today announced that several prototypes from its Innovation Lab are now available for public demonstrations. The Boston-based Innovation Lab continuously explores pervasive telemetry for clinical research and broad clinical care.
The objective of the ERT Innovation Lab is to reduce risk while helping pharmaceutical companies and CROs meet clinical trial objectives more efficiently and reliably. Technology vendors and biopharmaceutical organizations partner with ERT clinical scientists and developers to rapidly conceive and test prototypes for implementation. Although most Innovation Lab projects remain under strict non-disclosure, ERT is able to offer public demonstrations of select concepts in development, including:
- Biosensor with Fall Detection and Pulse Rate Diary Integration
- Electronic Clinical Outcome Assessment (eCOA) Study Designer for Rapid Prototyping
- CleverCap™ Medication Dispensing Integration
“Our broad goal in operating the Innovation Lab is to expand the art of the possible for pharmaceutical research,” said James Munz, Vice President of Innovation at ERT. “By enabling industry to leverage the Innovation Lab with minimal risk and rapid prototype deployment, we hope to remove barriers, enable researchers to embrace new medical technologies and foster an environment for researchers to think more broadly about how to evaluate the complete patient experience during clinical development.”
ERT is the leading global cloud platform solutions provider with over forty years experience delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions. The ERT Insights Cloud harmonizes data across the entire eClinical landscape to provide pharmaceutical researchers the most comprehensive view of the clinical development lifecycle. ERT is helping to meet the demands of the next generation of clinical research that faces its clients, which includes 95% of the top 50 global pharmaceutical, biotech and contract research organizations.
ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.